Authors: Altarescu, G Hill, S Wiggs, E Jeffries, N Kreps, C Parker , CC Brady, RO Barton, NW Schiffmann, R Bannarjee, TK Crutchfield, K Frei, K McKee, MA Moore, DF Tournay, A

Citation: G. Altarescu et al., The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease, J PEDIAT, 138(4), 2001, pp. 539-547

Authors: Stryker, VL Kreps, C

Citation: Vl. Stryker et C. Kreps, Fabry disease, AM J NURS, 101(4), 2001, pp. 39-44

Authors: Altarescu, G Schiffmann, R Parker, CC Moore, DF Kreps, C Brady, RO Barton, NW

Citation: G. Altarescu et al., Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease, BL CELL M D, 26(4), 2000, pp. 285-290

Authors: Schiffmann, R Murray, GJ Treco, D Daniel, P Sellos-Moura, M Myers, M Quirk, JM Zirzow, GC Borowski, M Loveday, K Anderson, T Gillespie, F Oliver, KL Jeffries, NO Doo, E Liang, TJ Kreps, C Gunter, K Frei, K Crutchfield, K Selden, RF Brady, RO

Citation: R. Schiffmann et al., Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease, P NAS US, 97(1), 2000, pp. 365-370